Overview

Alnylam Pharmaceuticals, Inc. is a clinical-stage company. The Company is engaged in developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead...

Open

$0.00

Prior close

$165.00

Today's high

$0.00

Today's low

$0.00

52 Week high

$479.79

52 Week low

$156.00

News

Zacks Investment Research • 3 days ago • ALNY

ALNY Stock Down 25% Despite Q3 Earnings Beat on Demand Growth Concerns

GlobeNewsWire • 4 days ago • ALNY

Lost Money on Alnylam Pharmaceuticals, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Continues Investigating Possible Securities Fraud After 28.31% Share Price Drop

Seeking Alpha • 4 days ago • ALNY

Alnylam Pharmaceuticals, Inc. (ALNY) Q3 2026 Earnings Call Transcript

MarketBeat • 4 days ago • ALNY

Alnylam Pharmaceuticals Q3 Earnings Call Highlights

Zacks Investment Research • 4 days ago • ALNY

Alnylam Pharmaceuticals (ALNY) Q3 Earnings and Revenues Top Estimates